Adapting a commercially available software program to improve ADR reporting

Ries, Andrea J.; Kraynak, Maura A.
November 1995
Formulary;Nov95, Vol. 30 Issue 11, p697
Academic Journal
Describes the University of Texas Health Science Center at San Antonio's adoption of a commercially available software program to develop a relational adverse drug reaction (ADR) database and compile and generate monthly ADR reports. Types of fields of entries; ADR database subsets; Capabilities gained through implementation of the software.


Related Articles

  • Pulmozyme for bronchitis .  // Drug Topics;5/23/94, Vol. 138 Issue 10, p64 

    Reports that DNase, the approved biotechnology drug for cystic fibrosis, improved survival in hospitalized patients with chronic bronchitis. Research at the University of Texas Health Science Center in San Antonio.

  • Boning up in A&E. Pierce, Julia // Engineer (00137758);4/4/2003, Vol. 291 Issue 7624, p15 

    No abstract available.

  • Can adverse drug reactions be detected earlier? A comparison of reports by patients and... Egberts, Toine C.G.; Smulders, Maartje // BMJ: British Medical Journal (International Edition);8/31/96, Vol. 313 Issue 7056, p530 

    Presents a study on the early detection of known and unknown adverse drug reactions. Incidence of patient and doctor reporting of drug side effects; Impact on pharmacovigilance.

  • New form increases adverse drug reaction reporting. Tan, K.M. // Physician Executive;May1995, Vol. 21 Issue 5, p37 

    Reports on the use of an adverse drug reaction report system at the Kaiser Permanente hospital in Richmond, California. Development of the report form by Charles Clemons and Patrick Graham; Description of the form; Increase in the number of adverse drug reaction reports; Benefits from the system.

  • Rx for doctors: Inform consumers about side effects.  // People's Medical Society Newsletter;Aug95, Vol. 14 Issue 4, p6 

    Cites a study in the December 12/24, 1995 issue of `Archives of Internal Medicine,' on doctors' failure to warn consumers about newly prescribed drugs' side effects because they feel the power of suggestion will increase incidence of those side effects. Educated consumer's greater responsibility...

  • Death of a dream? Day, Michael // New Scientist;12/06/97, Vol. 156 Issue 2111, p14 

    Reports that the side effects of Prozac (selective serotonin re-uptake inhibitors) and other anti-depressant drugs have been underestimated. What Prozac is used for; Length of time the SSRIs have been on sale in Britain; Comments from Ralph Edwards, director of the World Health Organization...

  • Drug points.  // BMJ: British Medical Journal (International Edition);1/6/96, Vol. 312 Issue 7022, p44 

    Reports on the policy of questioning authors who report on side effects of drugs by the British Medical Journal. Who to contact to make queries.

  • An update on Japan's direct adverse events reporting system.  // Reactions Weekly;May2014, Vol. 1500 Issue 1, p2 

    The article focuses on the pilot programme of the Direct Patient Reporting System for Adverse Drug Reactions launched by the Pharmaceuticals and Medical Devices Agency of Japan.

  • Adverse drug reactions: Finding the needle in the haystack. Edwards, I. Ralph // BMJ: British Medical Journal (International Edition);08/30/97, Vol. 315 Issue 7107, p500 

    Editorial. Discusses the need for cascading the benefits of pharmacovigilance or preventing adverse drug reactions to patients through immediate reporting by pharmacists. Barriers to pharmacists' reporting of adverse drug reactions; Gap between the development of pharmacovigilance knowledge...


Read the Article

Other Topics